GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Plandai Biotechnology Inc (OTCPK:PLPL) » Definitions » Operating Margin %

Plandai Biotechnology (Plandai Biotechnology) Operating Margin % : 0.00% (As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is Plandai Biotechnology Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Plandai Biotechnology's Operating Income for the six months ended in Jun. 2023 was $-0.71 Mil. Plandai Biotechnology's Revenue for the six months ended in Jun. 2023 was $0.00 Mil. Therefore, Plandai Biotechnology's Operating Margin % for the quarter that ended in Jun. 2023 was 0.00%.

The historical rank and industry rank for Plandai Biotechnology's Operating Margin % or its related term are showing as below:


PLPL's Operating Margin % is not ranked *
in the Diversified Financial Services industry.
Industry Median: 3.725
* Ranked among companies with meaningful Operating Margin % only.

Plandai Biotechnology's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Plandai Biotechnology's Operating Income for the six months ended in Jun. 2023 was $-0.71 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.71 Mil.

Warning Sign:

Plandai Biotechnology Inc has never been profitable in the past 3 years. It lost money every year.


Plandai Biotechnology Operating Margin % Historical Data

The historical data trend for Plandai Biotechnology's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Plandai Biotechnology Operating Margin % Chart

Plandai Biotechnology Annual Data
Trend Mar09 Mar10 Mar11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun22 Jun23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,783.46 -9,516.13 -1,043.29 - -

Plandai Biotechnology Semi-Annual Data
Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09 Mar10 Mar11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun22 Jun23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,783.46 -9,516.13 -1,043.29 - -

Competitive Comparison of Plandai Biotechnology's Operating Margin %

For the Shell Companies subindustry, Plandai Biotechnology's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Plandai Biotechnology's Operating Margin % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Plandai Biotechnology's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Plandai Biotechnology's Operating Margin % falls into.



Plandai Biotechnology Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Plandai Biotechnology's Operating Margin % for the fiscal year that ended in Jun. 2023 is calculated as

Operating Margin %=Operating Income (A: Jun. 2023 ) / Revenue (A: Jun. 2023 )
=-0.706 / 0
= %

Plandai Biotechnology's Operating Margin % for the quarter that ended in Jun. 2023 is calculated as

Operating Margin %=Operating Income (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=-0.706 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Plandai Biotechnology  (OTCPK:PLPL) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Plandai Biotechnology Operating Margin % Related Terms

Thank you for viewing the detailed overview of Plandai Biotechnology's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Plandai Biotechnology (Plandai Biotechnology) Business Description

Traded in Other Exchanges
N/A
Address
4811 49th Street, San Diego, CA, USA, 92115
Plandai Biotechnology Inc. manufactures highly bioavailable extracts from live plant materials.
Executives
Callum Baylis-duffield director FLAT 37 ISLAND HOUSE THREE MILL LANE, LONDON ENGLAND X0 E33AF
Timothy Matula other: Former Director 175 JACKSON AVE N, SUITE 102, MINNEAPOLIS MN 55343
Brian Johnson director P.O. BOX 1594, FERNDALE WA 98248-1594
Roger Duffield director, officer: President, Secretary and CFO 2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
Daron Baylis Duffield director 2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
David Rzepnicki director 21 HORIZON DRIVE, SARATOGA SPRINGS NY 12866

Plandai Biotechnology (Plandai Biotechnology) Headlines